Cybersecurity Solutions for Pharma and Life Sciences
Cybersecurity solutions for pharma and life sciences organizations reduce exposure to ransomware, intellectual property theft, operational disruption, and regulatory risk.
At Covert Threat, we evaluate security across research environments, laboratory systems, cloud platforms, and connected infrastructure responsible for handling sensitive scientific and healthcare-related data.
Let's Validate Your Security—For Real.
Prove What Actually Holds
If your defenses haven’t been tested under real attack conditions, they are unproven. We validate what actually holds—before it’s exploited.
- No generic assessments
- No junior resources
- No assumptions—only validated risk
Pharmaceutical and Research Organizations Are High-Value Targets
Attackers Target Intellectual Property, Clinical Data, and Connected Research Systems
Understanding the Risk
Pharma and life sciences organizations manage highly valuable research data, clinical trial records, manufacturing systems, and regulated healthcare information. Threat actors target these environments through ransomware attacks, phishing campaigns, vulnerable applications, and compromised credentials.
Security weaknesses across research platforms, cloud infrastructure, and third-party integrations increase operational exposure and elevate the risk of data compromise.
What Cybersecurity Solutions for Pharma and Life Sciences Covers
Cybersecurity for pharma and life sciences organizations assesses enterprise networks, research systems, cloud environments, applications, laboratory infrastructure, and external exposure points for exploitable weaknesses.
Covert Threat identifies risks impacting intellectual property, manufacturing operations, scientific data, and regulatory obligations. Engagements include penetration testing, vulnerability assessments, incident response planning, attack surface analysis, and adversary-led security validation.
Key Capabilities
- Research Environment Security Testing: Research systems, laboratory environments, and connected infrastructure are evaluated for vulnerabilities affecting scientific operations and sensitive data security.
- Cloud Infrastructure Assessment: Cloud-hosted applications, storage environments, and research platforms are reviewed for insecure permissions, exposed assets, and identity-related weaknesses.
- Application Security Testing: Web applications, research portals, and connected business platforms are tested for exploitable vulnerabilities that could impact sensitive organizational information.
- Vulnerability Assessment Services: Systems are evaluated for outdated software, insecure configurations, exposed services, and missing patches.
- Phishing & Social Engineering Testing: Employees are tested through simulated phishing campaigns designed to identify credential theft risks and human-focused security weaknesses.
- Operational Technology Security Review: Connected manufacturing and operational systems are assessed for vulnerabilities capable of disrupting production and business continuity.
- Identity & Access Control Review: Administrative privileges, authentication systems, and user permissions are analyzed for weaknesses impacting sensitive research and operational environments.
- Incident Response Planning: Organizations receive guidance for responding to ransomware, data compromise, insider threats, and operational security incidents affecting scientific operations.
- Third-Party Exposure Analysis: Vendors, external integrations, and connected systems are reviewed for security weaknesses impacting pharma and life sciences infrastructure.
What You Will Receive
Protect Research Data and Scientific Operations From Cyber Threats
- Security Assessment Report: A detailed report outlines vulnerabilities, exposed systems, operational risks, and remediation recommendations affecting research and enterprise environments.
- Executive Risk Summary: Leadership receives a concise overview of organizational exposure, business impact, and high-priority findings identified throughout the engagement.
- Technical Findings Documentation: Security teams receive technical evidence, vulnerability details, attack paths, and remediation guidance addressing identified security weaknesses.
- Risk Remediation Roadmap: Organizations receive prioritized recommendations focused on reducing exposure, strengthening controls, and improving cybersecurity readiness across operations.
- Reduced Exposure to Cyberattacks: Security weaknesses affecting research systems, manufacturing environments, and sensitive organizational data are identified before attackers can exploit them.
- Improved Protection for Intellectual Property: Organizations gain visibility into risks impacting proprietary research, clinical data, and regulated healthcare-related information systems.
- Stronger Operational Security: Testing identifies vulnerabilities capable of disrupting scientific operations, manufacturing systems, and interconnected infrastructure across the organization.
- Better Incident Readiness: Teams gain clearer response procedures and visibility into risks associated with ransomware, phishing, and unauthorized access activity.
OT/ICS Security Testing
Overlooked Flaw
Insufficient segmentation between IT and OT networks enabling cross-environment compromise.
100+
Proven Experience
Completed 100+ OT/ICS engagements uncovering critical pathways into industrial systems.
Operational Technology environments support critical infrastructure across energy, oil & gas, utilities, manufacturing, and water systems—where security failures can have physical and safety consequences. Testing focuses on industrial control systems, SCADA networks, and the convergence between IT and OT environments.
Aligned with NERC CIP, NIST, and industry-specific standards, these assessments identify how cyber threats can impact operational continuity and safety. The goal is to uncover pathways attackers can use to move from IT into OT systems, disrupt operations, or manipulate critical processes.
Why Choose CovertThreat?
Adversary-Led Security Validation
Our assessments simulate realistic attacker behavior targeting research systems, cloud platforms, manufacturing environments, and sensitive organizational data.
Experienced Security Specialists
Certified professionals conduct assessments across enterprise infrastructure, operational technology systems, applications, and cloud-hosted environments.
Regulated Industry Experience
We understand the operational and compliance challenges facing pharma and life sciences organizations handling sensitive scientific and healthcare data.
Executive-Level Reporting
Findings are translated into clear business language, helping leadership teams understand exposure levels and remediation priorities quickly.
Speak directly with our senior security experts.
FAQs
FAQs
Attackers target intellectual property, clinical research data, manufacturing systems, healthcare information, and interconnected operational environments within these industries.
Assessments include research environments, cloud infrastructure, applications, manufacturing systems, endpoints, authentication platforms, and internet-facing services.
Common threats include ransomware, phishing attacks, credential theft, insider threats, application vulnerabilities, and unauthorized access to sensitive research data.
